UnitedHealth Faces Challenges Amid Earnings and Regulatory Scrutiny
UnitedHealth Group's stock, which has fallen over 40% this year due to various challenges, is expected to experience a significant move of over 7% following its upcoming Q2 earnings report, with analysts remaining largely bullish despite recent troubles.